Citations

Mayo Clinic

Showing 10 of 108572 citations.

Utility Of diaphragm ultrasound in myopathy
O’Gorman, Cullen , OʼBrien, Travis G., Boon, Andrea J. , O'Gorman, Cullen M, O'gorman, Cullen M

Muscle & Nerve | October 12, 2016 | Volume: 55 | Issue: 3 | Pages: 427-429

10.1002/mus.25429 | PMID 27701744 Get It

Age at natural menopause genetic risk score in relation to age at natural menopause and primary open-angle glaucoma in a US-based sample
Pasquale, Louis R. , Bailey, Jessica N. Cooke , Lindström, Sara , Christen, William G. , Allingham, R. Rand, Ashley‐Koch, Allison E. , Lee, Richard K., Moroi, Sayoko E. , Brilliant, Murray H. , Wollstein, Gadi , Schuman, Joel S. , Fingert, John H. , Budenz, Donald L. , Realini, Tony , Gaasterland, Terry , Gaasterland, Douglas, Scott, William K. , Singh, Kuldev, Sit, Arthur J. , Igo, Robert P. , Song, Yeunjoo E. , Rhee, Douglas J. , Gulati, Vikas , Havens, Shane , Vollrath, Douglas, Medeiros, Felipe A. , Pericak‐Vance, Margaret A. , Kraft, Peter , Richards, Julia E. , Rosner, Bernard , Hauser, Michael A. , Haines, Jonathan L. , Wiggs, Janey L. , Aschard, Hugues , Kang, Jae Hee , Chasman, Daniel I. , Hark, Lisa A. , Ritch, Robert , Zack, Donald J. , Weinreb, Robert Neal , Liu, Yutao , Kraft, Peter , Moroi, Sayoko E , Schuman, Joel S , Sit, Arthur J

Menopause | October 12, 2016 | Volume: 24 | Issue: 2 | Pages: 150-156

10.1097/gme.0000000000000741 | PMID 27760082 Get It

Abstract Objective: Several attributes of female reproductive history, including age at natural menopause (ANM), have been related to primary open-angle glaucoma (POAG). We assembled 18 previously reported common genetic variants that predict ANM to determine their association with ANM or POAG. Methods: Using data from the Nurses’ Health Study (7,143 women), we validated the ANM weighted genetic risk score in relation to self-reported ANM. Subsequently, to assess the relation with POAG, we used data from 2,160 female POAG cases and 29,110 controls in the National Eye Institute Glaucoma Human Genetics Collaboration Heritable Overall Operational Database (NEIGHBORHOOD), which consists of 8 datasets with imputed genotypes to 5.6+ million markers. Associations with POAG were assessed in each dataset, and site-specific results were meta-analyzed using the inverse weighted variance method. Results: The genetic risk score was associated with self-reported ANM (P = 2.2 × 10–77) and predicted 4.8% of the variance in ANM. The ANM genetic risk score was not associated with POAG (Odds Ratio (OR) = 1.002; 95% Confidence Interval (CI): 0.998, 1.007; P = 0.28). No single genetic variant in the panel achieved nominal association with POAG (P ≥0.20). Compared to the middle 80 percent, there was also no association with the lowest 10th percentile or highest 90th percentile of genetic risk score with POAG (OR = 0.75; 95% CI: 0.47, 1.21; P = 0.23 and OR = 1.10; 95% CI: 0.72, 1.69; P = 0.65, respectively). Conclusions: A genetic risk score predicting 4.8% of ANM variation was not related to POAG; thus, genetic determinants of ANM are unlikely to explain the previously reported association between the two phenotypes.
Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells
Taipaleenmäki, Hanna , Farina, Nicholas H. , Wijnen, André J. van , Stein, Janet L. , Hesse, Eric , Stein, Gary S., Lian, Jane B. , van Wijnen, Andre J, van Wijnen, Andre J

Oncotarget | October 12, 2016 | Volume: 7 | Issue: 48 | Pages: 79032-79046

10.18632/oncotarget.12593 | PMID 27738322 Get It

Internal Medicine Residency Program Directors’ Views of the Core Entrustable Professional Activities for Entering Residency: An Opportunity to Enhance Communication of Competency Along the Continuum
Angus, Steven V., Vu, T. Robert , Willett, Lisa L. , Call, Stephanie, Halvorsen, Andrew J. , Chaudhry, Saima

Academic Medicine | October 12, 2016 | Volume: 92 | Issue: 6 | Pages: 785-791

10.1097/acm.0000000000001419 | PMID 28557944 Get It

Purpose To examine internal medicine (IM) residency program directors’ (PDs’) perspectives on the Core Entrustable Professional Activities for Entering Residency (Core EPAs)—introduced into undergraduate medical education to further competency-based assessment—and on communicating competency-based information during transitions. Method A spring 2015 Association of Program Directors in Internal Medicine survey asked PDs of U.S. IM residency programs for their perspectives on which Core EPAs new interns must or should possess on day 1, which are most essential, and which have the largest gap between expected and observed performance. Their views and preferences were also requested regarding communicating competency-based information at transitions from medical school to residency and residency to fellowship/employment. Results The response rate was 57% (204/361 programs). The majority of PDs felt new interns must/should possess 12 of the 13 Core EPAs. PDs’ rankings of Core EPAs by relative importance were more varied than their rankings by the largest gaps in performance. Although preferred timing varied, most PDs (82%) considered it important for medical schools to communicate Core EPA-based information to PDs; nearly three-quarters (71%) would prefer a checklist format. Many (60%) would be willing to provide competency-based evaluations to fellowship directors/employers. Most (> 80%) agreed that there should be a bidirectional communication mechanism for programs/employers to provide feedback on competency assessments. Conclusions The gaps identified in Core EPA performance may help guide medical schools’ curricular and assessment tool design. Sharing competency-based information at transitions along the medical education continuum could help ensure production of competent, practice-ready physicians.
Hepatocyte Growth Factor Is Positively Associated With Risk of Stroke
Bell, Elizabeth J. , Decker, Paul A. , Pankow, James S. , Tsai, Michael Y. , Hanson, Naomi Q., Wassel, Christina L. , Longstreth, W. T., Bielinski, Suzette J. , Larson, Nicholas B. , Decker, Paul A. , Bielinski, Suzette , Pankow, James S

Stroke | October 12, 2016 | Volume: 47 | Issue: 11 | Pages: 2689-2694

10.1161/strokeaha.116.014172 | PMID 27729582 Get It

Background and Purpose— Hepatocyte growth factor (HGF) is positively associated with ischemic and hemorrhagic stroke risk factors. However, understanding the relation between HGF and stroke is in its infancy. Therefore, we sought to examine the association of circulating HGF with incident stroke using data from the MESA (Multi-Ethnic Study of Atherosclerosis). We hypothesized that circulating HGF would be positively associated with an increased risk of stroke. Methods— Participants aged 45 to 84 years (n=6711) had HGF measured between 2000 and 2002 and were followed for incident stroke through 2013 (n=233). Cox proportional hazards regression was used to calculate hazard ratios and 95% confidence intervals for incident stroke. A secondary analysis stratified results by adjudicated stroke type (n=183 ischemic; n=39 hemorrhagic; n=11 other). Results— After adjustment for potential confounding variables, risk of stroke was 17% higher with each standard deviation increase in HGF (hazard ratio, 1.17; 95% confidence interval, 1.03–1.34). This association was mainly driven by ischemic stroke and did not change on exclusion of cardioembolic strokes, although the number of excluded cases was small. The few hemorrhagic and other types of stroke were not associated with HGF. Conclusions— Circulating HGF was positively associated with the incidence of stroke in a diverse, population-based cohort of men and women from the United States. Our findings support the hypothesis that circulating HGF is a marker of endothelial damage and suggest that HGF may have utility as a prognostic marker of stroke risk.
The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment
Muchtar, Eli , Jevremović, Dragan , Dispenzieri, Angela , Dingli, David , Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Russell, Stephen J. , Lust, John A., Lin, Yi , Chakraborty, Rajshekhar , Zeldenrust, Steven R., Kumar, Shaji , Kyle, Robert A. , Gertz, Morie A , Buadi, Francis K. , Gonsalves, Wilson I. , Leung, Nelson , Go, Ronald S. , Rajkumar, S. Vincent , Gertz, Morie A. , Muchtar, E , Dispenzieri, Angela , Russell, Stephen J , Jevremovic, Dragan , Chakraborty, Rajshekhar , Dingli, David , Lin, Yi

Blood | October 12, 2016 | Volume: 129 | Issue: 1 | Pages: 82-87

10.1182/blood-2016-06-721878 | PMID 27729322 Get It

Key PointsThe monotypic and polytypic PC compartments assessed by MFC are prognostic in AL amyloidosis. MFC may play a role in the definition of hematologic response to treatment.
Biomechanical analysis of the effect of congruence, depth and radius on the stability ratio of a simplistic ‘ball-and-socket’ joint model
Werthel, J-D., Thoreson, Andrew R. , Resch, Herbert, An, K-N, Moroder, Philipp , Ernstbrunner, Lukas , Werthel, J.D., Hatta, Taku , An, K-N.

Bone & Joint Research | October 12, 2016 | Volume: 5 | Issue: 10 | Pages: 453-460

10.1302/2046-3758.510.bjr-2016-0078.r1 | PMID 27729312 Get It

ObjectivesThe bony shoulder stability ratio (BSSR) allows for quantification of the bony stabilisers in vivo. We aimed to biomechanically validate the BSSR, determine whether joint incongruence affects the stability ratio (SR) of a shoulder model, and determine the correct parameters (glenoid concavity versus humeral head radius) for calculation of the BSSR in vivo.MethodsFour polyethylene balls (radii: 19.1 mm to 38.1 mm) were used to mould four fitting sockets in four different depths (3.2 mm to 19.1mm). The SR was measured in biomechanical congruent and incongruent experimental series. The experimental SR of a congruent system was compared with the calculated SR based on the BSSR approach. Differences in SR between congruent and incongruent experimental conditions were quantified. Finally, the experimental SR was compared with either calculated SR based on the socket concavity or plastic ball radius.ResultsThe experimental SR is comparable with the calculated SR (mean difference 10%, sd 8%; relative values). The experimental incongruence study observed almost no differences (2%, sd 2%). The calculated SR on the basis of the socket concavity radius is superior in predicting the experimental SR (mean difference 10%, sd 9%) compared with the calculated SR based on the plastic ball radius (mean difference 42%, sd 55%).ConclusionThe present biomechanical investigation confirmed the validity of the BSSR. Incongruence has no significant effect on the SR of a shoulder model. In the event of an incongruent system, the calculation of the BSSR on the basis of the glenoid concavity radius is recommended. Cite this article: L. Ernstbrunner, J-D. Werthel, T. Hatta, A. R. Thoreson, H. Resch, K-N. An, P. Moroder. Biomechanical analysis of the effect of congruence, depth and radius on the stability ratio of a simplistic ‘ball-and-socket’ joint model. Bone Joint Res 2016;5:453–460. DOI: 10.1302/2046-3758.510.BJR-2016-0078.R1.
Noninvasive Electromagnetic Source Imaging and Granger Causality Analysis: An Electrophysiological Connectome (eConnectome) Approach
He, Bin , Sohrabpour, Abbas , Ye, Shuai , Worrell, Gregory A. , Zhang, Wenbo , He, Bin

IEEE Transactions on Biomedical Engineering | October 11, 2016 | Volume: 63 | Issue: 12 | Pages: 2474-2487

10.1109/tbme.2016.2616474 | PMID 27740473 Get It

Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction
Zakeri, Rosita , Chai, Qiang , Ogut, Ozgur, Takahama, Hiroyuki , Lü, Tong , Wang, Xiaoli , Linke, Wolfgang A. , Lee, Hon-Chi, Redfield, Margaret M. , Moulay, Gilles , Hussain, Saad, Chai, Qiang, Hussain, Saad Abdulrahman , Wang, Xiao-Li, Lu, Tong , Linke, Wolfgang A , Zakeri, Rosita

Circulation: Heart Failure | October 11, 2016 | Volume: 9 | Issue: 10 | Pages: No page available

10.1161/circheartfailure.115.003238 | PMID 27758811 Get It

Background— Left atrial (LA) compliance and contractility influence left ventricular stroke volume. We hypothesized that diminished LA compliance and contractile function occur early during the development of heart failure with preserved ejection fraction (HFpEF) and impair overall cardiac performance. Methods and Results— Cardiac magnetic resonance imaging, echocardiography, left ventricular and LA pressure-volume studies, and tissue analyses were performed in a model of early HFpEF (elderly dogs, renal wrap-induced hypertension, exogenous aldosterone; n=9) and young control dogs (sham surgery; n=13). Early HFpEF was associated with LA enlargement, cardiomyocyte hypertrophy, and enhanced LA contractile function (median active emptying fraction 16% [95% confidence interval, 13–24]% versus 12 [10–14]%, P =0.008; end-systolic pressure-volume relationship slope 2.4 [1.9–3.2]mm Hg/mL HFpEF versus 1.5 [1.2–2.2]mm Hg/mL controls, P =0.01). However, atrioventricular coupling was impaired and the curvilinear LA end-reservoir pressure-volume relationship was shifted upward/leftward in HFpEF (LA stiffness constant [β LA ] 0.16 [0.11–0.18]mm Hg/mL versus 0.06 [0.04–0.10]mm Hg/mL controls; P =0.002), indicating reduced LA compliance. Impaired atrioventricular coupling and lower LA compliance correlated with lower left ventricular stroke volume. Total fibrosis and titin isoform composition were similar between groups; however, titin was hyperphosphorylated in HFpEF and correlated with β LA . LA microvascular reactivity was diminished in HFpEF versus controls. LA microvascular density tended to be lower in HFpEF and inversely correlated with β LA . Conclusions— In early-stage hypertensive HFpEF, LA cardiomyocyte hypertrophy, titin hyperphosphorylation, and microvascular dysfunction occur in association with increased systolic and diastolic LA chamber stiffness, impaired atrioventricular coupling, and decreased left ventricular stroke volume. These data indicate that maladaptive LA remodeling occurs early during HFpEF development, supporting a concept of global myocardial remodeling.
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
Beer, Tomasz M. , Kwon, Eugene D., Drake, Charles G. , Fizazi, Karim , Gravis, Gwénaëlle , Ganju, Vinod , Polikoff, Jonathan, Humanski, Piotr, Piulats, Josep M. , Mella, Pablo González, Ng, Siobhan, Jaeger, Dirk, Parnis, Francis, Franke, Fábio , Puente, Javier , Carvajal, Roman, Sengeløv, Lisa, McHenry, M. Brent , Varma, Arvind , Eertwegh, Alfonsus JM. van den, Gerritsen, Winald R. , Logothetis, Christopher, Saad, Fred, Gonzalez Mella, Pablo, Ng, Siobhan S, Parnis, Francis X, Franke, Fabio A, van den Eertwegh, Alfonsus J, Gerritsen, Winald, Logothetis, Christopher J. , Saad, Fred , Eertwegh, Alfonsus Johannes Maria van den, Gravis, Gwenaelle , Beer, Tomasz M

Journal of Clinical Oncology | October 11, 2016 | Volume: 35 | Issue: 1 | Pages: 40-47

10.1200/jco.2016.69.1584 | PMID 28034081 Get It

Purpose Ipilimumab increases antitumor T-cell responses by binding to cytotoxic T-lymphocyte antigen 4. We evaluated treatment with ipilimumab in asymptomatic or minimally symptomatic patients with chemotherapy-naive metastatic castration-resistant prostate cancer without visceral metastases. Patients and Methods In this multicenter, double-blind, phase III trial, patients were randomly assigned (2:1) to ipilimumab 10 mg/kg or placebo every 3 weeks for up to four doses. Ipilimumab 10 mg/kg or placebo maintenance therapy was administered to nonprogressing patients every 3 months. The primary end point was overall survival (OS). Results Four hundred patients were randomly assigned to ipilimumab and 202 to placebo; 399 were treated with ipilimumab and 199 with placebo. Median OS was 28.7 months (95% CI, 24.5 to 32.5 months) in the ipilimumab arm versus 29.7 months (95% CI, 26.1 to 34.2 months) in the placebo arm (hazard ratio, 1.11; 95.87% CI, 0.88 to 1.39; P = .3667). Median progression-free survival was 5.6 months in the ipilimumab arm versus 3.8 with placebo arm (hazard ratio, 0.67; 95.87% CI, 0.55 to 0.81). Exploratory analyses showed a higher prostate-specific antigen response rate with ipilimumab (23%) than with placebo (8%). Diarrhea (15%) was the only grade 3 to 4 treatment-related adverse event (AE) reported in ≥ 10% of ipilimumab-treated patients. Nine (2%) deaths occurred in the ipilimumab arm due to treatment-related AEs; no deaths occurred in the placebo arm. Immune-related grade 3 to 4 AEs occurred in 31% and 2% of patients, respectively. Conclusion Ipilimumab did not improve OS in patients with metastatic castration-resistant prostate cancer. The observed increases in progression-free survival and prostate-specific antigen response rates suggest antitumor activity in a patient subset.